BPC-157 contains four proline residues, including an unusual triple-proline sequence that gives the peptide its exceptional stability
BPC-157 Peptide Therapy offers a targeted way to stimulate the bodys own healing abilities by encouraging tissue growth, improving blood circulation to damaged areas, and controlling inflammation
Pyridoxine: Pyridoxine should not be administered to patients already receiving levodopa, because it is an antagonist of pyridoxine
This systemic action makes it particularly interesting for disc herniations, where the injury site is difficult to access directly
This guide covers how each delivery method works, the core clinical differences between them, who benefits most from each option, and what to expect regarding side effects, treatment frequency, and cost